SEARCH

SEARCH BY CITATION

Keywords:

  • apoptosis;
  • intestinal epithelium

Abstract

  1. Top of page
  2. Abstract
  3. INTRODUCTION
  4. APOPTOSIS IN THE GASTROINTESTINAL TRACT
  5. REFERENCES

Apoptosis is now recognized as an important process responsible for maintenance of the cellular balance between proliferation and death. Apoptosis is distinct from necrosis in that it is a programmed form of cell death and occurs without any accompanying inflammation. This form of cell death can be induced by a wide range of cellular signals, which leads to activation of cell death machinery within the cell and is characterized by distinct morphological changes. Apoptosis is especially relevant in the gastrointestinal tract, as the mammalian intestinal mucosa undergoes a process of continual cell turnover that is essential for maintenance of normal function. Cell proliferation is confined to the crypts, while differentiation occurs during a rapid, orderly migration up to the villus. The differentiated enterocytes, which make up the majority of the cells, then undergo a process of programmed cell death (apoptosis). Although apoptosis is essential for the maintenance of normal gut epithelial function, dysregulated apoptosis is seen in a number of pathological conditions in the gastrointestinal tract. The cellular mechanisms regulating this tightly regimented process have not been clearly defined and this topic represents an area of active investigation as delineation of this process will lead to a better understanding of normal gut mucosal growth.


INTRODUCTION

  1. Top of page
  2. Abstract
  3. INTRODUCTION
  4. APOPTOSIS IN THE GASTROINTESTINAL TRACT
  5. REFERENCES

Types of cellular death processes

Cell death occurs in multicellular organisms by either of two well-characterized mechanisms, depending on the context and cause of death. Until approximately 25 years ago, cell death was considered harmful and detrimental to the body, as the clearly identified mechanism of cell death was necrosis. Cells that undergo necrotic death release their cytoplasmic and nuclear contents into the intercellular milieu, thus sparking inflammation. In the early 1970s, Kerr et al. coined the term apoptosis (derived from the Greek word for ‘falling off’) for a characteristic type of cell death observed morphologically. 1 The studies on the nematode worm, Caenorhabditis elegans, served to reawaken interest in this field after the discovery of specific genes that control the apoptotic process during development. 2 This indicated that apoptosis, unlike necrosis, was a genetically controlled form of cell death and the floodgates of information on this topic were opened. Apoptotic cell death has since been identified as a novel physiological process that is conserved during evolution and plays an important role in deleting senescent, damaged, redundant and deleterious cells from multicellular organisms. It is a form of ‘cell suicide’ and although induced by a wide range of signals, is a tightly controlled process occurring in a regulated and sequential manner. The various signals inducing apoptosis and the pathways by which the cellular components bring about this process have been under intense investigation in recent years. This has resulted in a burst of information on the intricate relationship between various components of the apoptotic cascade and insight into the functioning and regulation of the apoptotic pathway. The widespread occurrence of apoptosis has provoked efforts aimed at defining the cellular mechanisms and biochemical processes controlling it, which, in turn, may help in formulating new therapeutic strategies.

Apoptosis occurs following a specific sequence of events

Apoptosis can be induced when cells receive death-inducing stimuli; for example, lack of growth or survival factors, oxygen deficiency, metabolic defects, physical and chemical damage and/or binding of particular ligands to death receptors, like Fas, on the cell surface. 3,4 Once the cell surface death receptors (e.g. Fas receptors) are activated, their cytosolic domains bind to adapter proteins such as the Fas-associated death domain protein, which, in turn, links up with caspase-8 to form the death-induced signaling complex (DISC; 5Fig. 1).

image

Figure 1. The signalling cascade during apoptosis. The attachment of Fas with its receptor on the cell surface leads to its binding with adapter proteins, such as the Fas-associated death domain (FADD). This complex then binds to and activates caspase-8, forming a multiprotein complex called the death-induced signalling complex (DISC). Caspase-8 can then either directly activate other members of the caspase family, or cleave pro-Bid to form Bid. Bid translocates to mitochondria and induces release of cytochrome c, which, along with the apoptosis activating factor 1 (Apaf-1) activates caspase-9. Caspase-9 can then activate down-stream caspases. The activated caspases bring about the final morphological features of apoptosis, such as DNA fragmentation and phosphatidylserine externalization. Cyt. c, cytochrome c.

Download figure to PowerPoint

The initiation stage of apoptosis is followed by a signalling stage, where mitochondria are known to play a central role. 6 During apoptosis, mitochondria undergo characteristic changes including a non-specific increase in membrane permeability, which develops gradually, 7 and a reduction of mitochondrial membrane potential, 8 which is accompanied by oxidative stress. 9 Cytochrome c, a component of the mitochondrial respiratory chain residing exclusively in the intermembrane space of the mitochondria, is released into the cytosol during apoptosis. 10–12 This release of cytochrome c from mitochondria can be blocked by Bcl-2, 13 an anti-apoptotic protein localized in mitochondria, 14 while Bax, a pro-apoptotic member of the Bcl-2 family that translocates from the cytosol to the mitochondria during apoptosis, 15 induces cytochrome c release. 16,17 Recently, a mitochondrial apoptosis-inducing factor that translocates from mitochondria to nucleus during apoptosis was characterized. 18

This signalling phase is followed by the execution phase of apoptosis, during which the activated apoptotic machinery acts on multiple cellular targets. The final executioners of apoptosis are the caspases, which are cysteine-containing aspartate-specific proteases, activated during apoptosis in almost all cell types. 19 These proteases are synthesized as proenzymes and when activated by proteolytic cleavage during apoptosis, 19,20 specifically degrade a number of cellular substrates such as poly(ADP-ribose) polymerase, lamin B and DNA topoisomerases I and II. 21 Caspase-8, once activated in the multiprotein DISC complex, has two major functions. It can directly activate further down-stream caspases 22 which bring about the final morphological features of apoptosis 20,23 and also induce release of cytochrome c from the mitochondria. 24 The released cytochrome c binds to an apoptosis activating factor-1 (Apaf-1), which in turn activates caspase-9 and amplifies the proteolytic cascade. 14 Bcl-2 could play a role here too, by regulating Apaf-1 and preventing activation of down-stream caspases. 14

The caspases thus bring about degradation of cellular components and activation of specific endonucleases which cleave DNA, 25,26 resulting in degradation of chromatin. Cross-linking of proteins by transglutaminase, an enzyme whose activity is modulated by Ca2+, guanosine triphosphate (GTP), S-nitrosylation and polyamines, 27 keeps the apoptotic bodies intact during fragmentation of the cell. 28 Following this, the interactions of the individual cell with its neighbours become disorganized 29 and membrane changes are initiated in the apoptotic cell, 21 which enable apoptotic cell uptake by macrophages. 30,31 Thus, apoptosis occurs without leakage of intracellular macromolecules, 32 and without any inflammation.

Reactive-oxygen species are important physiological effectors of apoptosis

Reactive-oxygen species (ROS) such as superoxide anion, hydrogen peroxide, organic peroxides and radicals are generated by cells as by-products of normal metabolism and these compounds have now been implicated as signalling molecules in apoptosis. Studies have demonstrated that apoptosis appears to be the major mode of cell death when cells experience a lethal oxidative insult from exposure to ROS. 33 Hydrogen peroxide from hepatocytes has been shown to induce apoptosis in sinusoidal endothelial cells in the liver 34 and H2O2 also mediates neutrophil apoptosis. 35 Hydrogen peroxide-mediated and iron-catalysed lysosomal rupture causes decompartmentalization of lysosomal enzymes, which may play a role in modulating the apoptotic process. 36 Oxidized low-density lipoproteins and lipid hydroperoxides have also been shown to induce apoptosis. 37,38

Other than oxidants from the external medium, ROS generated within the cell itself can modulate the apoptotic process. Reactive-oxygen species generated at the ubiquinone site of the mitochondrial respiratory chain have been implicated as mediators in ceramide-induced apoptosis. 39 Fas ligation induces ROS production, which could be prevented by an NADPH oxidase inhibitor, implicating this oxidase system in generation of ROS during apoptosis. 40 Superoxide may be produced from mitochondria due to a switch over from the normal four-electron reduction of O2 to a one-electron reduction when cytochrome c is released from the mitochondria. Bcl-2 is able to prevent this cytochrome c release as well as the superoxide generation. 33 Bcl-2 has also been shown to protect against oxidant-induced cell death by increasing the capacity of mitochondria to store calcium. 41 Oxidants have been implicated in p53-mediated apoptosis also 42 and p53 probably induces synthesis of specific proteins that increase the cellular ROS content, leading to mitochondrial damage and further down-stream events. 43 The biochemical mechanisms that can be activated by ROS during induction of apoptosis, may be seen at several central points in the cellular apoptosis regulatory systems and recent data also implicate ROS in a dual role in apoptosis: first, as a facultative signal during the induction phase; and second, as a common consequence of mitochondrial permeability transition, leading to final destruction of the cell. 44

APOPTOSIS IN THE GASTROINTESTINAL TRACT

  1. Top of page
  2. Abstract
  3. INTRODUCTION
  4. APOPTOSIS IN THE GASTROINTESTINAL TRACT
  5. REFERENCES

Epithelial cells in the gastrointestinal tract have a high turnover and as it is essential to maintain a normal cell balance, cell death, especially apoptosis, is crucial for maintenance of normal morphology and function. Despite being inconspicuous in histological material, apoptosis probably accounts for the bulk of cell loss in the gut and is a central feature of the regulation of cell numbers in adult tissues. 45 Hence, it is interesting to understand the role of apoptosis, its inducers and regulation, with reference to the gastrointestinal (GI) tract. The intestinal villi consist of differentiated absorptive cells that originate from the intestinal crypts. The crypt stem cells proliferate to produce the epithelial cells, which migrate upward and proliferate several times before reaching villi as differentiated epithelial cells ( Fig. 2). Given the existence of this dynamic system, where cell proliferation has to be counterbalanced by cell death, the gastrointestinal tract offers an ideal system to study the apoptotic process in vivo. Apoptosis maintains the structure of the colonic crypts by providing a balance to the rate of cell proliferation. Defective apoptosis, which results in the failure of cells to die in response to premalignant damage, may allow the progression of disease and maintain the resistance of colon cancer cells to cytotoxic therapy, 46 again illustrating the importance of apoptosis in the GI tract. Thus, it is of interest to know the mechanism and the various physiological inducers of apoptosis, as well as the role apoptosis plays in pathological states of the gastrointestinal tract.

image

Figure 2. Schematic representation of the intestinal epithelium in (a) normal and (b) pathological conditions. Normally, the differentiated villus cells at the tip undergo apoptosis (▪) in order to maintain homeostasis as the rapidly proliferating cells are at the crypt. In pathological conditions, excessive apoptosis of villus cells can cause shortening of the villi.

Download figure to PowerPoint

Physiological occurrence of apoptosis in the gastrointestinal tract

The intestinal mucosa has cells at various stages of differentiation from the immature crypt stem cells to the differentiated cells of the villus. Feedback signals from the villus to crypt cells regulate proliferation and these seem to be mediated by growth factors, such as epidermal growth factor, transforming growth factor-alpha and -beta3 (TGF-α, TGF-β3), mainly in the crypts. Although TGF-α stimulates, and TGF-β inhibits proliferation, 47 TGF-β resistant cells were found to lose contact inhibition and develop resistance to butyrate-induced apoptosis. 48 An autocrine TGF-β loop has been proposed to mediate the anti-proliferative effect of interleukin (IL)-2 in the intestinal epithelial cell (IEC) line, IEC-6. 49 Given the presence of cells at different stages of maturation along the crypt–villus axis, it seems logical that the differentiated villus cells are likely to die by apoptosis and be extruded into the lumen or taken up by macrophages and removed, but demonstration of this phenomenon has been riddled with controversy. Although studies have shown apoptosis in crypt stem cells, 50 work from our laboratory and others indicates that apoptosis occurs predominantly in the villus tip cells. 51,52 Apoptosis has been shown to occur in the rat small intestinal mucosa, predominantly at the villus tip, forming a prominent ‘apoptotic cuff’ of cells, while all cells in the crypt expressed Bcl-2 activity. 53 Immunoreactivity for Bcl-2 or Bax was found to be intense in cells that were prone to becoming apoptotic next in the course of cell turnover, but not in cells in an advanced apoptotic state. 54 In chicken caecal epithelium, apoptotic cells with intense DNA fragmentation were seen at the villus tip, suggesting that these cells were exfoliated into the lumen after the induction of apoptosis, a process probably mediated by lymphocytes. 55 Macrophages and lymphocytes have been implicated in the removal of apoptotic cells from the villus tip. 56 Transmission electron microscopy studies have shown protruding enterocytes at the villus tip, with nuclear chromatin condensation, immediately before being exfoliated into the lumen. The intercellular spaces beneath these protruding cells are often occupied by large lymphocytes, 57 which probably do not engulf aged enterocytes, but induce their apoptosis. 58

Another cytokine with an important role in apoptosis in the GI tract is tumour necrosis factor (TNF). Tumour necrosis factor has been shown to induce apoptosis and detachment of enterocytes of the villus tip in mice, 59 probably by induction of caspase activity. 60 Tumour necrosis factor-α has also been shown to induce apoptosis in IEC-66 cells, although the cells died by necrosis when the caspase cascade was inhibited. 61 It has also been suggested that, in order to ensure rapid epithelial renewal of the villi and maintenance of a functional barrier, IEC eliminate infected and senescent cells through a combination of cytotoxicity, interferon (IFN)-γ and TNF release. 59 Tumour necrosis factor probably acts on its receptor 1 (TNFR1) to induce apoptotic detachment of the enterocytes from the tip of the villi, while increasing expression of p53 via either TNFR1 or TNFR2 in the crypt, to inhibit apoptosis. 62 Human tumour (HT)-29 cells were found to display a dual response to TNF-α and Fas antigen ligation: when in combination with interferon (IFN)-γ, HT-29 cells underwent apoptosis, whereas independently these factors stimulated secretion of IL-8. 63

Although a large amount of data on the mechanisms and inducers of apoptosis are available, most of the work has been on cell lines and little information is available on the mechanisms and the inducers involved in apoptosis of the enterocyte in vivo. Studies from our laboratory have demonstrated a possible role of oxidative stress in the monkey normal villus epithelial cell apoptosis. 64 It was seen that there was an imbalance between oxidants and anti-oxidants, which can activate apoptosis in the villus cells while the crypt stem cells were normal. The increased apoptosis in the villus enterocytes were also associated with increased efflux of glutathione 51 and low activity of superoxide dismutase compared with crypt stem cells. 64 This compromised anti-oxidant defence may affect the neutralization of ROS in the villus cells and may facilitate their apoptosis. Our studies further indicated structural and functional changes in the mitochondria associated with apoptosis of the villus tip cells. 65 It was observed that villus mitochondria had a lower respiratory control ratio compared with crypt cells and they also showed an increase in the mitochondrial permeability transition. Mitochondrial lipid analysis indicated activation of a phospholipase D enzyme in the apoptotic villus cells, which probably facilitated the functional alterations. 65 Phospholipase D activation was found to occur in a time-dependent manner during apoptosis and this activation, as well as apoptosis, was effectively suppressed by caspase inhibitors. 66 The secretory phospholipase A2 inhibitor p-bromophenacyl bromide was also seen to produce a dose-dependent increase in apoptotic ratios in both IEC-6 and colon cancer cell line WB-2054-M4. 67

Detachment-induced cell death can occur in a number of cell types, and although it is a recognized form of apoptosis in IEC, 68 whether the cells detach before actually dying is still controversial. A number of studies support this form of apoptosis and it is said to be one of the mechanisms by which IEC die as they reach the villi of the intestine before being extruded into the lumen or taken up by macrophages. DNA fragmentation was observed 90 min after detachment of human IEC and was preceded by the sequential activation of preformed members of the CPP32 family of caspases. 69 Apoptosis was seen in mouse intestinal cells 90 min after detachment and this was prevented by caspase inhibitors, 70 indicating that activation of caspases plays a role in the apoptosis of these cells. Although a recent report indicated that DNA fragmentation could precede cell elimination by days in the small intestinal villus, 71 the technique used for detection of apoptotic cells in the study, namely in situ end labelling, is prone to false results.

The link between differentiation and apoptosis has also been demonstrated in the intestine derived cell lines and these were found to occur simultaneously in Caco-2 cells, suggesting that apoptosis may be linked to enterocyte differentiation. The induction of p21Waf1/Cip1 and p27Kip1 and the down-regulation of Bcl-2 and Bcl-XL further suggest a link between the cell cycle mechanisms regulating enterocyte differentiation and apoptosis. 72 Interferon-γ, depending on its concentration, has both differentiation- and apoptosis-inducing effects on the colon derived HT-29 cells; low concentrations induce differentiation while higher concentrations induce apoptosis. 73 Another study using the colorectal adenoma cell line PC/BH/C1 showed that butyrate-induced apoptosis was preceded by the induction of two markers of colonic differentiation, namely alkaline phosphatase activity and E-cadherin, which were not seen in TGF-β1-induced cell death. The study concluded that sodium butyrate induced apoptosis via differentiation, but that TGF-β1 induced apoptosis by a differentiation-independent mechanism. 74

Another inducing factor for apoptosis in the GI tract is lack of nutrients for cellular metabolism. Glutamine is the most abundant amino acid in the blood and is the preferred oxidative fuel for IEC. Glutamine deprivation has been shown to induce apoptosis in IEC, 75 suggesting that glutamine serves as a specific survival factor for enterocytes. Butyrate is the preferred fuel for colonic epithelial cells and removal of butyrate induces increased expression of bax proteins, paralleled by rapid apoptosis of colonocytes in vitro. 76

Apoptosis in pathological states of the gastrointestinal tract

Apoptosis plays an important role in a number of pathological conditions of the gastrointestinal tract and this could be due either to an increase or decrease in the rate of cell death. For example, enterocyte apoptosis was found to be greatly increased in coeliac disease, indicating that increased apoptosis may be responsible for the villous atrophy seen in this disease. 77 Loss of epithelial cells in active ulcerative colitis (UC) occurs mainly by apoptosis in crypts of the involved and adjacent uninvolved areas 78 and this unscheduled apoptosis in the UC crypts is probably mediated by autocrine or paracrine Fas–Fas ligand (FasL) interaction. 79 Soluble FasL-mediated epithelial cell apoptosis in UC may also lead to the breakdown of epithelial barrier function, facilitating the invasion of pathogenic microorganisms, 80 a phenomenon also seen in apoptosis induced by doxorubicin, where increased apoptosis and increased bidirectional permeability of the intestinal barrier occur simultaneously. 81 Decreased apoptosis has been implicated in the pathogenesis of gastric carcinoma by the finding that microsatellite mutations in the Bax gene are common in these patients, suggesting that Bax may be an important apoptotic inducer and tumour suppressor in the stomach. 82

Ischaemia–reperfusion as an inducer of apoptosis in the gastrointestinal tract

Ischaemia–reperfusion is a well-characterized clinical entity, which is known to induce tissue damage, especially during conditions such as transplantation. The small intestine is highly sensitive to ischaemia–reperfusion and we have previously shown that the rat intestinal mitochondria was irreversibly damaged by long periods of ischaemia or ischaemia followed by reperfusion, while the damage induced by short periods of ischaemia was reversible. 83 Studies have now shown that apoptosis in the rat small intestine is induced by ischaemia of the gut and this process is exacerbated by reperfusion. 84 Apoptosis after ischaemia–reperfusion was also demonstrated in transplantation of intestinal grafts in the rat. 85

Cancer of the gastrointestinal tract and the role of Bcl-2 family proteins in dysregulated apoptosis

Maintenance of normal cell numbers in tissue requires a balance between the rate of cell division and cell death. Uncontrolled cell proliferation seen in malignancy could be the result of an increased proliferation and/or decreased apoptosis. In normal colonic mucosa, Bcl-2-positive epithelial cells tend to be localized to the base of the crypt, while Bax- and Bak-positive epithelial cells are located at the luminal surface. 86 Bcl-2 is an important anti-apoptotic protein, which can even prevent caspase-independent cell death. 87 Many colorectal tumours have elevated levels of Bcl-2, sug-gesting that the deregulated Bcl-2 expression may be important in tumour development. 88 It is possible that nutritional stress conditions in colonic tumours may contribute to Bcl-2 up-regulation 89 and Bcl-2 may play an important role in the early stage of the adenoma–carcinoma sequence, down-regulation of Bcl-2 being associated with risk of malignant transformation for colorectal adenoma. 90 Although the Bcl-2 oncoprotein inhibits apoptosis in adenoma and adenocarcinoma, mutations in another important tumour suppressor, the p53 oncoprotein might block apoptosis in adenocarcinoma. 91 p53 also plays a role in 5-fluorouracil-induced apoptosis in crypts of both the small intestine and midcolon, 92 and is accompanied by changes in RNA metabolism, which probably initiate events culminating in the expression of p53. 93 But again, p53 is not frequently found to be mutated in colorectal carcinomas with the microsatellite mutator phenotype, where frame-shift mutations within the gene for a pro-apoptotic member of the Bcl-2 family, Bax, are frequently found. This suggests that mutations in Bax, rather than mutations in p53, may contribute to the adenoma–carcinoma transition in hereditary non-polyposis colorectal cancer tumorigenesis. 94Bax expression may be an additional prognostic marker in colorectal carcinomas 86 and butyrate deprivation increased expression of Bax in guinea-pig proximal colon, accompanied by oligonucleosomal DNA fragmentation and massive apoptosis of colonocytes. 95 Expression of Bax was strong in colonic adenocarcinomas 96 and more than 50% of human microsatellite mutator phenotype colon adenocarcinomas were found to have frame-shift mutations in the Bax gene, suggesting that wild type Bax plays a suppressor role in a p53-independent pathway for colorectal carcinogenesis. 97,98 Another member of the Bcl-2 family is Bak, which is an important regulator of apoptosis in normal IEC 99,100 and has been found to be down-regulated in a high proportion of colorectal tumours. 101 Activation of the oncogene Ras, induces the down-regulation of Bak in human IEC and this is probably important for the transforming ability of the Ras oncogene. 102

Apoptosis and inflammatory bowel disease

A number of immune system-mediated bowel disorders, including coeliac disease, Crohn’s disease and UC are characterized by accelerated epithelial cell turnover and apoptosis, leading to altered crypt/villus morphology. These changes, and the accompanying functional alterations of the bowel epithelium, are probably mediated by the cytokines released from infiltrating inflammatory cells, as well as from enterocytes themselves, acting in an autocrine fashion. 103 Polymorphonuclear neutrophil (PMN) apoptosis may be delayed under the influence of soluble mediators, especially granulocyte-colony stimulating factor, in the microenvironment of inflammatory bowel disease (IBD)-affected mucosa, thus providing a possible mechanism for tissue accumulation of PMN in IBD. 104 Activated macrophages are derived from circulating monocytes and appear to play a major role in the pathogenesis of IBD and are an important mechanism for loss of resident macrophages from normal mucosa in apoptosis. 105 T cells isolated from areas of inflammation in Crohn’s disease, UC and other inflammatory states manifest decreased apoptosis and studies of cells from inflamed Crohn’s disease tissue indicate that this defect is accompanied by elevated Bcl-2 levels. 106 The Bcl-2/Bax ratio is significantly higher in Crohn’s disease and lower in UC, indicating that Crohn’s disease may represent a disorder where the rate of cell proliferation exceeds the rate of cell death and insufficient T cell apoptosis may result in inappropriate T cell accumulation, causing changes in tolerance and chronic inflammation. 107 Fas ligation induces apoptosis of colonic epithelial cells and is implicated in the epithelial damage seen in UC, whereby Fas–FasL interactions in the intestinal mucosa may lead to complex signal transduction cascades and gene regulation that culminate in apoptosis. 108 Fas is expressed constitutively by colonic epithelial cells, and FasL is expressed by CD3 lymphocytes infiltrating into UC lesions, suggesting that Fas–FasL induced apoptosis participates in the mucosal damage of UC. 109 Accelerated epithelial cell turnover caused by chronic inflammation and epithelial cell damage might predispose the mucosa to DNA damage, resulting in an elevated risk of mutation in line with dysplasia and carcinoma development in patients with UC. 110 Colon cancer cells have been found to express functional FasL, 111 suggesting that this has a role in bestowing immune privilege on human tumours and that these cells are insensitive to the anti-FasL agonistic monoclonal antibody. This indicates that cancer cells resist Fas-mediated cytotoxicity but express functional FasL, an apoptotic death signal to which activated T cells are inherently sensitive. 112

Bacterial infection and apoptosis

Epithelial cells that line the human intestinal mucosa are the initial site of host invasion by bacterial pathogens. Human colon epithelial cells undergo apoptosis following invasion with invasive enteric pathogens such as Salmonella or entero-invasive Escherichia coli. This apoptosis occurs 6 h after bacterial infection and TNF-α and nitric oxide (NO) are important mediators in this process. 113 Verotoxin-producing, attaching and effacing E. coli also induce apoptosis in infected enterocytes. 114 Shiga toxin from Shigella dysenteriae and Shiga-like toxin from enterohaemorrhagic E. coli cause apoptosis in the mature, differentiated absorptive villus epithelium of rabbit intestine. 115

Shigella species cause bacillary dysentery in humans by invading epithelial cells of the colonic mucosa, which leads to colonic epithelial cell destruction and inflammation. The acute phase of shigellosis inflammation is characterized by increased cell turnover in the lamina propria and the epithelium, and apoptosis of the lamina propria macrophages. 116,117 Invasion of the intestinal barrier by Shigella flexneri involves complex interactions with epithelial and phagocytic cells 118 and initial bacterial entry occurs essentially via M cells of the follicular-associated epithelium. It then causes apoptosis of macrophages located in the follicular dome, inducing release of IL-1β, which in turn initiates inflammation and destabilization of epithelial structure. 119,120

Toxigenic strains of the anaerobic bacterium Clostridium difficile produce at least two large, single-chain protein exotoxins involved in the pathogenesis of antibiotic-associated diarrhoea and colitis. Intestinal cells exposed to toxin B underwent apoptosis with nuclear fragmentation and chromatin condensation 121 and exposure to toxin A induced epithelial cell rounding, detachment and apoptosis in organ cultures of human colonic biopsy specimens. 122 Exposure of HT-29 colon carcinoma cells to Clostridium difficile toxin A for 24 h also induced IL-8 production. 122

The bacterium, Helicobacter pylori has been under intense scrutiny recently, having been implicated in the aetiology of various conditions. Helicobacter pylori colonization of the stomach has been found to result in more apoptotic cells than normal ones 123,124 and this reverted back to normal on eradication of the organism. 123Helicobacter pylori is also capable of inducing apoptosis in epithelial cells in vitro. 124 Although the exact mechanism by which H. pylori induces apoptosis is not known, the available data indicate that it may be through various mediators. Monochloramine (NH2Cl) is known to be one of the virulence factors in H. pylori-associated gastric mucosal injury and monochloramine was found to induce DNA fragmentation, one of the characteristic features of apoptosis, in the gastric cell line MKN45. 125 Adherence also seems to be necessary for apoptosis induction, 126 but high doses of purified H. pylori lipopolysaccharide can also induce apoptosis 124 and major histocompatibility class II molecules have also been implicated in the process. 127 The immune response associated with infection may also influence apoptosis after H. pylori infection. Inflammatory mediators, such as IFN-γ and TNF-α, augment apoptosis induced by H. pylori128,129 and IFN-γ has been shown to up-regulate the Fas receptor on gastric epithelial cells. 129 Consequent to H. pylori infection, elevated expression of Fas antigen was seen in mucosal cells, concurrent with Fas ligand expressing lymphocytes. Thus, apoptosis in H. pylori-associated gastric and duodenal ulcer disease may be mediated by the Fas pathway. 130 Apoptosis induced by H. pylori in gastric epithelial cells was also accompanied by increased expression of Bak, with little change in expression of other Bcl-2 family members. The expression of Bak was also increased in gastric biopsies from patients colonized by H. pylori. It appears that H. pylori induces gastric epithelial cell apoptosis by a Bak-dependent pathway. 126

Radiation-induced apoptosis

The radiosensitivity of proliferating crypt epithelial cells makes the gut a major limiting factor in the use of radiotherapy for treatment of abdominal cancers. As the post-mitotic epithelial cells migrate from the small intestinal crypts to the base of adjacent villi they rapidly lose their ability to undergo apoptosis in response to ionizing radiation and, hence, it is the crypt cells that are more susceptible to radiation-induced apoptosis. 131 Various studies have shown an increase in apoptosis after radiotherapy, especially in the crypts. Very small doses of radiation can elevate the level of apoptosis in the crypt stem cells and the oncoprotein p53 is involved in recognizing radiation-induced damage and initiating apoptosis. This apoptosis plays an important role in the gut in terms of homeostasis and its protection against carcinogenesis by removal of potentially carcinogenically damaged cells. 132 The level of apoptosis was dramatically elevated 3–6 h following ionizing radiation exposure, most frequently in the crypt-associated stem cells, 133 but loss of p53 essentially rendered epithelial cells, from both the small intestine and colon, radio-resistant. 134 p53 function seems to be essential for the normal response to gamma-irradiation-induced DNA damage in intestinal mucosal cells, and p53 deficiency permits a population of cells bearing DNA damage to escape the normal process of deletion. 135 However, other studies have indicated the existence of a delayed onset, p53-independent apoptotic mechanism, probably by mitotic catastrophe, at radiation doses of 8 Gy or more. 136 Differences have also been noted in the occurrence of radiation-induced apoptosis in the small and large intestine. Thus, it was seen that 3 h after whole-body irradiation of 8 Gy, the expression of p53 protein, as well as apoptosis, was much higher in the stem cell compartment of small intestine than in the colon. 134 Also, in the small intestine, peak levels of radiation-induced apoptosis appeared earlier than in the large intestine. 137 Small but statistically significant differences in radiation survival curves were observed along the length of the small intestine, but no difference was observed between the different regions of the large intestine. 138 Analysis of (CcS-7 × BALB/cHeA)F2 hybrid mice revealed linkage of susceptibility to radiation-induced apoptosis of colon crypt cells to two loci on chromosomes 9 and 16. 139 Studies have also shown that IL-11 can exert a potent effect on the recovery of small intestinal mucosa after treatment with combined chemotherapy and radiation by its combined effects on the proliferation and apoptosis of crypt cells. 140

Nitric oxide and apoptosis in the gastrointestinal tract

Nitric oxide is an important molecule with diverse roles, now being studied with great interest due to its role in modulation of apoptosis. It has been shown to induce apoptosis in cells such as macrophages and T84 tumour cells, 141,142 but prevent apoptosis in others. 143 Nitric oxide has an apoptosis-inhibiting effect mediated through the inhibition of caspases by S-nitrosylation 144,145 and NO also inhibits Fas-induced apoptosis. 146 Nitric oxide was found to reversibly inhibit the respiration of IEC and elevate the levels of Bcl-2. As Bcl-2 is an anti-apoptotic protein, this elevation may protect enterocytes against toxic effects of NO and, thus, NO might effectively exhibit its antibacterial action in the anaerobic intestinal lumen without inducing apoptosis of Bcl-2 enriched mucosal cells. 147 Nitric oxide has also been found to protect B lymphocytes from antigen-mediated apoptotic death, probably by preventing the drop in the expression of the proto-oncogene Bcl-2, 148 and inhibit spontaneous apoptosis in cultured ovarian follicles via a c-guanidine monophosphate (cGMP)-dependent mechanism. 149 It has been shown that NO prevents apoptosis in hepatocytes by inhibiting caspase-3-like protease activation through a cGMP-dependent mechanism and by direct S-nitrosylation of caspase-3. 150 Kim et al. have shown that NO inhibits cytochrome c release by preventing Bcl-2 cleavage by caspase-3. 11 Recently, NO was shown to inhibit execution of apoptosis at two distinct ATP-dependent steps up-stream and down-stream of mitochondrial cytochrome c release. The release of cytochrome c from mitochondria was delayed and the processing of procaspase 3 and 7 to the active protease was prevented even after cytochrome c was released. 151 Our studies showed that NO prevented damage induced by intestinal ischaemia–reperfusion 152 and our recent studies have indicated that NO can protect against hypoxia-induced apoptosis in HT-29 colon carcinoma cells by inhibiting cytochrome c release from mitochondria. 153

In conclusion, it appears that the apoptotic process plays an important role in the normal dynamic process of cell turnover in the intestinal epithelium. The apoptotic process in the IEC is a complex process involving a number of mediators ( Fig. 3). As the mammalian intestinal mucosa undergoes a process of continuous cell turnover, where cell proliferation is confined to the crypts and differentiation occurs during a rapid, orderly migration up to the villus, the increased proliferation has to be counterbalanced by a similar rate of cell death. The differentiated enterocytes, which make up the majority of cells in the intestinal epithelium, probably undergo a process of apoptosis at the villus tips to maintain tissue homeostasis. Increased apoptosis also plays an important role in damage induced by ischaemia–reperfusion injury and IBD. Apoptosis is also important for removal of damaged cells after radiation injury and bacteria use apoptosis to induce death of host cells and enable infection. A decreased rate of apoptosis has been implicated in carcinoma, where uncontrolled proliferation leads to disease.

image

Figure 3. Epithelial cell apoptosis in the gastrointestinal tract. Apoptosis can be induced in the epithelial cell under both physiological and pathophysiological conditions and these are mediated by various effector molecules in the cell. RCR, respiratory control ratio; Cyt. c, cytochrome c.

Download figure to PowerPoint

REFERENCES

  1. Top of page
  2. Abstract
  3. INTRODUCTION
  4. APOPTOSIS IN THE GASTROINTESTINAL TRACT
  5. REFERENCES
  • 1
    Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239 57.
  • 2
    Shaham S & Horvitz HR. Developing caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev 1996; 10: 578 91.
  • 3
    Buttke TM & Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol. Today 1994; 15: 7 10.
  • 4
    Nagata S & Goldstein P. The Fas death factor. Science 1995; 267: 1449 55.
  • 5
    Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 1996; 85: 817 27.
  • 6
    Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: Doubt no more. Biochem. Biophys. Acta 1998; 1366: 151 165.
  • 7
    Lemasters JJ, Nieminen AL, Qian T et al. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1998; 1366: 177 96.
  • 8
    Zamzami N, Marchetti P, Castedo M et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 1995; 181: 1661 72.
  • 9
    Backway KL, McCulloch EA, Chow S, Hedley DW. Relationships between the mitochondrial permeability transition and oxidative stress during ara-C toxicity. Cancer Res 1997; 57: 2446 51.
  • 10
    Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996; 86: 147 57.
  • 11
    Kim YM, Kim TH, Seol DW, Talanian R, Billiar TR. Nitric oxide suppression of apoptosis occurs in association with an inhibition of bcl-2 cleavage and cytochrome c release. J. Biol. Chem 1998; 273: 31 434 41.
  • 12
    Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481 90.
  • 13
    Yang J, Liu X, Bhalla K et al. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129 32.
  • 14
    Cory S & Adams JM. The Bcl-2 protein family: Arbiters of cell survival. Science 1998; 281: 1322 6.
  • 15
    Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle R. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 1997; 139: 1281 92.
  • 16
    Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 1998; 95: 4997 5002.
  • 17
    Eskes R, Antonsson B, Osen-Sand A et al. Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol 1998; 143: 217 24.
  • 18
    Susin SA, Lorenzo HK, Zamzami N et al. Molecular characterization of mitochondrial apoptosis inducing factor. Nature 1999; 397: 441 5.
  • 19
    Kidd VJ. Proteolytic activities that mediate apoptosis. Ann. Rev. Physiol 1998; 60: 533 73.
  • 20
    Martin SJ & Green D. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995; 82: 349 52.
  • 21
    Casiano CA, Martin SJ, Green D, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/AOP-1)-mediated T cell apoptosis. J. Exp. Med. 1996; 184: 765 70.
  • 22
    Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: The Fas/Apo-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple ced-3/ICE-like cysteine proteases. Proc. Natl Acad. Sci. USA 1996; 93: 14 486 91.
  • 23
    Porter AG & Janicke RU. Emerging roles of caspase 3 in apoptosis. Cell Death Differ. 1999; 6: 99 104.
  • 24
    Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD, Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem 1998; 273: 16 589 94.
  • 25
    Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43 50.
  • 26
    Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555 6.
  • 27
    Melino G & Piacentini M. Tissue transglutaminase in cell death: A downstream or a multifunctional upstream effector? FEBS Lett 1998; 430: 59 63.
  • 28
    Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 1987; 224: 104 8.
  • 29
    Ueda N & Shah SV. Apoptosis. J. Lab. Clin. Med 1994; 124: 169 77.
  • 30
    Fadock VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol 1992; 148: 2207 16.
  • 31
    Nakano T, Ishimoto Y, Kishino J et al. Cell adhesion to phosphatidyl serine mediated by a product of growth arrest specific gene 6. J. Biol. Chem 1997; 272: 29 411 14.
  • 32
    Wyllie AH. Apoptosis. Br. J. Cancer 1993; 67: 205 8.
  • 33
    Cai J & Jones DP. Superoxide in apoptosis: Mitochondrial generation triggered by cytochrome c loss. J. Biol. Chem 1998; 273: 11 401 4.
  • 34
    Motoyama S, Minamiya Y, Saito S et al. Hydrogen peroxide derived from hepatocytes induces sinusoidal endothelial cell apoptosis in perfused hypoxic rat liver. Gastroenterology 1998; 114: 153 63.
  • 35
    Labelle ER, Grange MJ, Elhim C, Marquetty C, Pocidalo MAG, Pasquier C. Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Rad. Biol. Med. 1998; 24: 563 72.
  • 36
    Hellquist HB, Svensson I, Brunk UT. Oxidant induced apoptosis: A consequence of lethal lysosomal leak? Redox Report 1997; 3: 65 70.
  • 37
    Escargueil I, Salvayre NA, Pieraggi MT, Salvayre R. Oxidized low density lipoproteins elicit DNA fragmentation of cultured lymphoblastoid cells. FEBS Lett 1992; 305: 155 9.
  • 38
    Sandstrom PA, Tebbey PW, Van Cleave S, Buttke TM. Lipid hydroperoxides induce apoptosis in T cells displaying a HIV associated glutathione peroxidase deficiency. J. Biol. Chem 1994; 269: 798 801.
  • 39
    Mary AQ, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem 1997; 272: 21 388 95.
  • 40
    Suzuki Y, Ono Y, Hirabayashi Y. Rapid and specific reactive oxygen generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett 1998; 425: 209 12.
  • 41
    Ichiyama M, Chang SH, Liu H, Berezesky IK, Trump BF, Amstad PA. Effect of Bcl-2 on oxidant-induced cell death and intracellular Ca2+ mobilization. Am. J. Physiol 1998; 275: C832 9.
  • 42
    Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl Acad. Sci. USA 1996; 93: 11 848 52.
  • 43
    Polyak K, Xia Y, Zweler JL, Kinzler KW, Vogelstein B. A model for p53 induced apoptosis. Nature 1997; 389: 300 5.
  • 44
    Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem. Pharmacol 1999; 57: 231 45.
  • 45
    Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J. Cell Sci 1994; 107: 3569 77.
  • 46
    Butler LM, Hewett PJ, Fitridge RA, Cowled PA. Deregulation of apoptosis in colorectal carcinoma: Theoretical and therapeutic implications. Aust. NZ J. Surg 1999; 69: 88 94.
  • 47
    Ruifrok AC, Mason KA, Lozano G, Thames HD. Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1–3 and their receptors in mouse jejunum after radiation treatment. Radiat. Res. 1997; 147: 1 12.
  • 48
    Sheng H, Shao J, O’Mahony CA et al. Transformation of intestinal epithelial cells by chronic TGF-betal treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Oncogene 1999; 18: 855 67.
  • 49
    Taheri A, Lavagna C, Rampal P. Effect of interleukin-2 on the proliferation of two intestinal cell lines and on the expression of TFG-beta gene and Jun/Fos oncogenes. Gastroenterol. Clin. Biol. 1993; 17: 925 31.
  • 50
    Potten CS & Loeffler M. Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110: 1001 20.
  • 51
    Benard O, Madesh M, Anup R, Balasubramanian KA. Apoptotic process in the monkey small intestinal epithelium. 1. Association with glutathione level and its efflux. Free Rad. Biol. Med 1999; 26: 245 52.
  • 52
    Moss SF & Holt PR. Apoptosis in the intestine (Letter). Gastroenterology 1999; 111: 567 8.
  • 53
    Westcarr S, Farshori P, Wyche J, Anderson WA. Apoptosis and differentiation in the crypt-villus unit of the rat small intestine. J. Submicrosc. Cytol. Pathol 1999; 31: 15 30.
  • 54
    Aschoff AP, Ott U, Funfstuck R, Stein G, Jirikowski GT. Colocalization of Bax and Bcl-2 in small intestine and kidney biopsies with different degrees of DNA fragmentation. Cell Tissue Res 1999; 296: 351 7.
  • 55
    Takeuchi T, Kitagawa H, Imagawa T, Uehara M. Apoptosis of villous epithelial cells and follicle associated epithelial cells in chicken cecum. J. Vet. Med. Sci 1999; 61: 149 54.
  • 56
    Iwanaga T. The involvement of macrophages and lymphocytes in the apoptosis of enterocytes. Arch. Histol. Cytol 1995; 58: 151 9.
  • 57
    Shibahara T, Sato N, Waguri S et al. The fate of effete epithelial cells at the villus tips of the human small intestine. Arch. Histol. Cytol. 1995; 58: 205 19.
  • 58
    Iwanaga T, Hoshi O, Han H, Takahashi-Iwanaga H, Uchiyama Y, Fujita T. Lamina propria macrophages involved in cell death (apoptosis) of enterocytes in the small intestine of rats. Arch. Histol. Cytol 1994; 57: 267 76.
  • 59
    Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Seris M, Vassalli P. Small bowel enteropathy: Role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol 1998; 28: 730 44.
  • 60
    Piguet PT, Vesin C, Donati Y, Barazzone C. TNF-induced enterocyte apoptosis and detachment in mice: Induction of caspases and prevention by a caspase inhibitor, ZVAD-fmk. Lab. Invest 1999; 79: 495 500.
  • 61
    Ruemmele FM, Dionne S, Levy E, Seidman EG. TNFα-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem. Biophys. Res. Commun 1999; 260: 159 66.
  • 62
    Piguet PT, Vesin C, Guo J, Donati Y, Barazzone C. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur. J. Immunol 1998; 28: 3499 505.
  • 63
    Abreu-Martin MT, Vidrich A, Lynch DH, Targan SR. Divergent induction of apoptosis and IL-8 secretion in HT29 cells in response to TNF-α and ligation of Fas antigen. J. Immunol. 1995; 155: 4147 54.
  • 64
    Madesh M, Benard O, Balasubramanian KA. Apoptotic process in the monkey small intestinal epithelium. 2. Possible role of oxidative stress. Free Rad. Biol. Med 1999; 26: 431 8.
  • 65
    Madesh M, Anup R, Benard O, Balasubramanian KA. Apoptosis in the monkey small intestinal epithelium: Structural and functional alterations in the mitochondria. Free Rad. Biol. Med 1999; 26: 836 43.
  • 66
    Kasai T, Ohguchi K, Nakashima S et al. Increased activity of oleate-dependent tyrosine phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells. J. Immunol 1998; 161: 6469 74.
  • 67
    Longo WE, Grossmann EM, Erickson B, Panesar N, Mazuski JE, Kaminski DL. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells. J. Surg. Res. 1999; 84: 51 6.
  • 68
    Grossman J, Fiocchi C, Levine AD. Extracellular matrix (ECM) orchestrates death and survival of human intestinal epithelial cells (IEC). Gastroenterology 1997; 112: A987.
  • 69
    Grossman J & Mohr S. Lapetina EG, Fiocchi C, Levine AD. Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am. J. Physiol 1998; 274: G1117 24.
  • 70
    Scheving LA, Jin WH, Chong KM, Gardner W, Cope FO. Dying enterocytes downregulate signaling pathways converging on Ras: Rescue by protease inhibition. Am. J. Physiol 1998; 274: C1363 72.
  • 71
    Pompeiano M, Hvola M, Chun J. Onset of apoptotic DNA fragmentation can precede cell elimination by days in the small intestinal villus cells. Cell Death Differ 1998; 5: 702 9.
  • 72
    Litvak DA, Evers M, Hwang KO, Hellmich MR, Ko TC, Townsend CM. Butyrate induced differentiation of Caco 2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 1998; 124: 161 70.
  • 73
    Veldman RJ, Klappe K, Hoekstra D, Kok JW. Interferon γ induced differentiation and apoptosis of HT29 cells: Dissociation of (glucosyl) ceramide signaling. Biochem. Biophys. Res. Commun 1998; 247: 802 8.
  • 74
    Butt AJ, Hague A, Paraskeva C. Butyrate, but not TGF B1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase. Cell Death Differ 1997; 4: 725 32.
  • 75
    Papaconstantinou HT, Hwang KO, Rajaraman S, Hellmich MR, TownsendJrCM, Ko TC. Glutamine deprivation induces apoptosis in intestinal epithelial cells. Surgery 1998; 124: 152 9.
  • 76
    Hass R, Busche R, Luciano L, Reale E, Engelhardt WV. Lack of butyrate is associated with induction of bax and subsequent apoptosis in proximal colon of guinea pig. Gastroenterology 1997; 112: 875 81.
  • 77
    Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR. Increased intestinal apoptosis in coeliac disease. Gut 1996; 39: 811 17.
  • 78
    Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol 1996; 180: 152 9.
  • 79
    Iwamoto M, Makiyama K, Koji T, Nakane PK. Expression of Fas and Fas-ligand in epithelium of ulcerative colitis. Nippon Rinsho 1996; 54: 1970 4.
  • 80
    Strater J, Wellisch I, Riedl S et al. CD95 (APO1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis. Gastroenterology 1997; 113: 160 7.
  • 81
    Sun Z, Wang X, Wallen R. The influence of apoptosis on intestinal barrier integrity in rats. Scand. J. Gastroenterol. 1998; 33: 415 22.
  • 82
    Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite type. Cancer Res 1997; 57: 4420 6.
  • 83
    Madesh M, Bhaskar L, Balasubramanian KA. Enterocyte viability and mitochondrial function after graded intestinal ischemia and reperfusion in rats. Mol. Cell. Biochem 1997; 167: 81 7.
  • 84
    Noda T, Iwakiri R, Fujimoto K, Matsuo S, Aw TY. Programmed cell death induced by ischemia–reperfusion in rat intestinal mucosa. Am. J. Physiol 1998; 274: G270 6.
  • 85
    Shah KA, Shurey S, Green CJ. Apoptosis after intestinal ischemia-reperfusion injury. Transplantation 1997; 64: 1393 7.
  • 86
    Ogura E, Senzaki H, Yamamoto D et al. Prognostic significance of Bcl-2, Bcl-XL/S, Bax and Bak expressions in colorectal carcinomas. Oncol. Rep. 1999; 6: 365 9.
  • 87
    Okuno S, Shimizu S, Ito T et al. Bcl-2 prevents caspase independent cell death. J. Biol. Chem 1998; 273: 34 272 7.
  • 88
    Hague A, Mooghen M, Hicks D, Chapman M, Paraskeva C. Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994; 9: 3367 70.
  • 89
    Paraskeva C & Singh B. Bcl-2 as a possible sensor of nutritional stress inhibiting apoptosis and allowing cell survival during colorectal carcinogenesis. Biochem. Soc. Trans 1998; 26: 236 41.
  • 90
    Yang HB, Chow NH, Sheu BS, Chan SH, Chein CH, Su IJ. The role of Bcl-2 in the progression of the colorectal adenoma-carcinoma sequence. Anticancer Res 1999; 19: 727 30.
  • 91
    Sun B, Zhang N, Zhao X. Apoptosis and expression of its regulating genes in adenoma and adenocarcinoma of large intestine. Chung Hua Ping Li Hsuch Tsa Chih 1997; 26: 137 40.
  • 92
    Pritchard DM, Potten CS, Hickman JA. The relationship between p53 dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res 1998; 58: 5453 65.
  • 93
    Pritchard DM, Watson AJM, Potten CS, Jackman AL, Hickman JA. Inhibition by uridine but not thymidine of p53 dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation. Proc. Natl Acad. Sci. USA 1997; 94: 1795 9.
  • 94
    Yagi OK, Akiyama Y, Nomizu T, Iwama T, Endo M, Yuasa Y. Proapoptotic gene Bax is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology 1998; 114: 268 74.
  • 95
    Hass R, Busche R, Luciano L, Reale E, Engelhardt WV. Lack of butyrate is associated with induction of bax and subsequent apoptosis in the proximal colon of guinea pig. Gastroenterology 1997; 112: 875 81.
  • 96
    Hirose Y, Yoshimi N, Suzui M, Kawabata K, Tanaka T, Mori H. Expression of Bcl-2, Bax and Bcl-XL proteins in azoxymethane-induced rat colonic adenocarcinomas. Mol. Carcinog 1997; 19: 25 30.
  • 97
    Rampino N, Yamamoto H, Ionov Y et al. Somatic frameshift mutations in the Bax gene in colon cancers of the microsatellite mutator phenotype. Science 1997; 275: 967 9.
  • 98
    Iacopetta BJ, Soong R, House AK, Hamelin R. Gastric carcinomas with microsatellite instability: Clinical features and mutations to the TGF-beta type II receptor, IGF II receptor and Bax genes. J. Pathol 1999; 187: 428 32.
  • 99
    Moss SF, Agarwal B, Arber N et al. Increased intestinal Bak expression results in apoptosis. Biochem. Biophys. Res. Commun. 1996; 223: 199 203.
  • 100
    Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res 1996; 56: 2849 55.
  • 101
    Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56: 2422 7.
  • 102
    Rosen K, Rak J, Jin J, Kerbel RS, Newman MJ, Filmus J. Down regulation of the pro-apoptotic protein Bak is required for the Ras-induced transformation of intestinal epithelial cells. Curr. Biol. 1998; 8: 1331 4.
  • 103
    Ruemmele FM & Seidman EG. Cytokine-intestinal epithelial cell interactions: Implications for immune mediated bowel disorders. Chung Hua Min Kuo Hsiao Erh Ko I Hseuh Hui Tsa Chih 1998; 39: 1 8.
  • 104
    Ina K, Kusugami K, Hosokawa T et al. Increased mucosal production of granulocyte colony stimulating factor is related to delay in neutrophil apoptosis in inflammatory bowel disease. J. Gastroenterol. Hepatol 1999; 14: 46 53.
  • 105
    McAlindon ME, Galvin A, McKaig B, Gray T, Sewell HF, Mahida YR. Investigation of the expression of IL-1 beta converting enzyme and apoptosis in normal and inflammatory bowel disease (IBD) mucosal macrophages. Clin. Exp. Immunol 1999; 116: 251 7.
  • 106
    Boirivant M, Marini M, DiFelice G et al. Lamina propria T cells in Crohn’s disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116: 557 65.
  • 107
    Ina K, Itoh J, Fukushima K et al. Resistance of Crohn’s disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol 1999; 163: 1081 90.
  • 108
    Abreu-Martin MT, Palladino AA, Faris M, Carramanzana NM, Nel AE, Targan SR. Fas activates the Jnk pathway in human colonic epithelial cells: Lack of a direct role in apoptosis. Am. J. Physiol 1999; 276: G599 605.
  • 109
    Ueyama H, Kiyohara T, Sawada N et al. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 1998; 43: 48 55.
  • 110
    Arai N, Mitomi H, Chtani Y, Igarashi M, Kakita A, Okayasu I. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Mod. Pathol. 1999; 12: 604 11.
  • 111
    Peduto EL, Guillou L, Saraga E et al. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas. Int. J. Cancer 1999; 81: 772 8.
  • 112
    O’Connell J, O’Sullivan GC, Colins JK, Shanahan F. The Fas counterattack: Fas mediated T-cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 1996; 184: 1075 82.
  • 113
    Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF. Apoptosis of human intestinal epithelial cells after bacterial invasion. J. Clin. Invest 1998; 102: 1815 23.
  • 114
    Wada Y, Mori K, Iwanaga T. Apoptosis of enterocytes induced by inoculation of a strain of attaching and effacing Escherichia coli and verotoxin. J. Vet. Med. Sci 1997; 59: 815 18.
  • 115
    Keenam KP, Sharpnack DD, Collins H, Formal SB, O’Brien AD. Morphologic evaluation of the effects of Shiga toxin and E. coli Shiga-like toxin on the rabbit intestine. Am. J. Pathol 1986; 125: 69 80.
  • 116
    Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature 1992; 358: 167 9.
  • 117
    Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. In-situ characterization of inflammatory responses in the rectal mucosa of patients with Shigellosis. Infect. Immun 1997; 65: 739 49.
  • 118
    Sansonetti PJ, Tran Van Nhieu G, Egile C. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri. Clin. Infect. Dis. 1999; 28: 466 75.
  • 119
    Sansonetti PJ. Molecular and cellular mechanisms of invasion of the intestinal barrier by enteric pathogens. The paradigm of Shigella. Folia Microbiol 1998; 43: 239 46.
  • 120
    Bloom PD & Boedeker EC. Mucosal immune responses to intestinal bacterial pathogens. Semin. Gastrointest. Dis 1996; 7: 151 66.
  • 121
    Fiorentini C, Fabbri A, Falzano L et al. Clostridium difficile toxin B induces apoptosis in intestinal cultured cells. Infect. Immun 1998; 66: 2660 5.
  • 122
    Mahida YR, Makh S, Hyde S, Gray T, Borriello SP. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: Induction of interleukin-8 production and apoptosis after cell detachment. Gut 1996; 38: 337 47.
  • 123
    Moss SF, Calam J, Agarwal B et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498 501.
  • 124
    Wagner S, Beil W, Westermann J et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis. Gastroenterology 1997; 113: 1836 47.
  • 125
    Suzuki H, Seto K, Mori H, Suzuki M, Miura S, Ishii H. Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am. J. Physiol 1998; 275: G712 16.
  • 126
    Chen G, Sordillo EM, Ramey WG et al. Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of Bak. Biochem. Biophys. Res. Commun 1997; 239: 626 32.
  • 127
    Fan X, Crowe SE, Behar S et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: A mechanism for T helper cell type 1 mediated damage. J. Exp. Med 1998; 187: 1659 69.
  • 128
    Rudi J, Kuck D, Krammer PH et al. Possible involvement of the APO-1/Fas (CD95) receptor/ligand system in H. pylori-induced apoptosis (Abstract). Gastroenterology 1997; 112: A274.
  • 129
    Behar S, Van Houten N, Bamford K et al. H. pylori induces apoptosis in gastric epithelial cells which is enhanced by cytokines derived from Th1 cells (Abstract). Gastroenterology 1996; 110: A862.
  • 130
    Houghton J, Korah RM, Condon MR, Kim KH. Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway. Dig. Dis. Sci. 1999; 44: 465 78.
  • 131
    Coopersmith CM & Gordon JI. Gamma-ray-induced apoptosis in transgenic mice with proliferative abnormalities in their intestinal epithelium: Re-entry of villus enterocytes into the cell cycle does not affect their radio-resistance but enhances the radiosensitivity of the crypt by inducing p53. Oncogene 1997; 15: 131 41.
  • 132
    Potten CS, Merritt A, Hickman J, Faranda A. Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int. J. Radiat. Biol 1994; 65: 71 8.
  • 133
    Potten CS & Grant HK. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br. J. Cancer 1998; 78: 993 1003.
  • 134
    Merritt AJ, Potten CS, Kemp CJ et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice. Cancer Res 1994; 54: 614 17.
  • 135
    Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994; 9: 1767 73.
  • 136
    Merritt AJ, Allen TD, Potten CS, Hickman JA. Apoptosis in the small intestinal epithelium from p53-null mice: Evidence for a delayed, p53 independent G2/M-associated cell death after gamma-irradiation. Oncogene 1997; 14: 2759 66.
  • 137
    Arai T, Kida Y, Harmon BV, Gobe GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br. J. Cancer 1996; 74: 406 12.
  • 138
    Cai WB, Roberts SA, Bowley E, Hendry JH, Potten CS. Differential survival of murine small and large intestinal crypts following ionizing radiation. Int. J. Radiat. Biol 1997; 71: 145 55.
  • 139
    Mori N, Van Wezel T, Van Der Valk M, Sakuma S, Okumoto M, Demant P. Genetics of susceptibility to radiation-induced apoptosis in colon: Two loci on chromosomes 9 and 16. Mamm. Genome 1998; 9: 377 80.
  • 140
    Orazi A, Du X, Yang Z, Kashai M, Williams DA. Interleukin 11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab. Invest 1996; 75: 33 42.
  • 141
    Cul S, Reichner JS, Mato RB, Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide dependent and independent mechanisms. Cancer Res 1994; 54: 2462 7.
  • 142
    Sandoval M, Zhang XJ, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: Attenuation by L-ascorbic acid. Free Radic. Biol. Med 1997; 22: 489 95.
  • 143
    Kim YM, De Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem 1997; 272: 1402 11.
  • 144
    Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by s-nitrosylation and oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun 1997; 238: 387 91.
  • 145
    Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature 1997; 388: 432 3.
  • 146
    Mannick JB, Miao XQ, Stamler J. Nitric oxide inhibits Fas induced apoptosis. J. Biol. Chem 1997; 272: 24 125 8.
  • 147
    Nishikawa M, Takeda K, Sato EF, Kuroki T, Inoue M. Nitric oxide regulates energy metabolism and bcl-2 expression in intestinal epithelial cells. Am. J. Physiol 1998; 274: G797 801.
  • 148
    Genaro AM, Hortelano S, Alvarez A, Martinez AC, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest 1995; 95: 1884 90.
  • 149
    Chun SY, Eisenhauer KM, Kubo M, Huseh AJW. Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 1995; 136: 3120 7.
  • 150
    Kim YM, Talanian RV, Billiar TR. Nitric oxide prevents apoptosis by preventing increases in caspase-3 like activity via two distinct mechanisms. J. Biol. Chem 1997; 272: 31 138 48.
  • 151
    Leist M, Single B, Naumann H et al. Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and down stream of mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun 1999; 258: 215 21.
  • 152
    Madesh M, Ramachandran A, Pulimood A, Vadranam M, Balasubramanian KA. Attenuation of intestinal ischaemia–reperfusion injury with sodium nitroprusside. Biochem. Biophys. Acta (2000) in press.
  • 153
    Madesh M & Anup R. Balasubramanian KA. Nitric oxide prevents anoxia-induced apoptosis in colonic HT29 cells. Arch. Biochem. Biophys 1999; 366: 240 8.